For: | Cherri S, Libertini M, Zaniboni A. New drugs for the treatment of metastatic colorectal cancer. World J Gastrointest Oncol 2021; 13(11): 1551-1560 [PMID: 34853636 DOI: 10.4251/wjgo.v13.i11.1551] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v13/i11/1551.htm |
Number | Citing Articles |
1 |
Weilong Yao, Longchuan Bai, Shaomeng Wang, Yifan Zhai, Shi-Yong Sun. Mcl-1 levels critically impact the sensitivities of human colorectal cancer cells to APG-1252-M1, a novel Bcl-2/Bcl-XL dual inhibitor that induces Bax-dependent apoptosis. Neoplasia 2022; 29: 100798 doi: 10.1016/j.neo.2022.100798
|
2 |
Axel Muendlein, Luciano Severgnini, Thomas Decker, Christine Heinzle, Andreas Leiherer, Kathrin Geiger, Heinz Drexel, Thomas Winder, Patrick Reimann, Frank Mayer, Christoph Nonnenbroich, Tobias Dechow. Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1045995
|
3 |
Robert Kubina, Kamil Krzykawski, Agata Kabała-Dzik, Robert D. Wojtyczka, Ewa Chodurek, Arkadiusz Dziedzic. Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review. Nutrients 2022; 14(13): 2604 doi: 10.3390/nu14132604
|